Potential use of radiolabeled glucuronide prodrugs with auger and/or alpha emitters in combined chemo- and radio-therapy of cancer

Current Pharmaceutical Design

Volumn 6, Issue 11, 2000, Pages 1127-1142

  Ünak, Turan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; BETA GLUCURONIDASE; GLUCURONIDE; IODINE 125; PRODRUG; RADIOISOTOPE;

ALPHA RADIATION; ANTINEOPLASTIC ACTIVITY; AUGER ELECTRON SPECTROSCOPY; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CYTOTOXICITY; DRUG DESIGN; HUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW;

EID: 0033925995     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612003399798     Document Type: Review

References (104)

1. Kauffman, J.M.; Foye, W.O. Cancer Chemotherapy in Principles of Medicinal Chemistry (Ed. : Foye, .O.), pp. 837-861. Philedelphia : Lea and Febiger, 1981.
2. Haskel, C.M. Principles and Practice of Cancer Chemotherapy in Cancer Treatment (Ed. : Haskel, C.M.), pp. 21-43. Philedelphia: W.B. Saunders Co., 1990.
3. Fishman, W.H.; Anlyan, A.J.; Gordon, E, Cancer Res., 1947, 7, 808.
4. Ardenne, M. von; Kr_ger, W.; Reitnauer, P.G. Agressology, 1977, 18, 135.
5. Workman, P.; Double, J.A. Biomedicine, 1984, 73, 1430.
6. Henle, K.J.; Monson, T.P.; Nagle, W.A.; Moss, A.J. Radiat. Res, 1988, 115, 234.
7. Bosman, H.B.; Hall, T.C. Proc. Natl. Acad. Sci. USA, 1974, 71, 1833.
8. Dobrossy, L.; Pavelic, Z.P.; Vaughan, M.; Proter, N.; Bernacki, R.J. Cancer Res., 1980, 40, 3281.
9. Wilman, D.E.V. Biochem. Soc. Trans., 1986, 14, 2, 375.
10. Springer, C.J.; Marais, R. Drug Delivery Rev., 1996, 22, 269.
11. Wang, S.M.; Chern, J.W.; Yeh, M.Y.; Ng, J.C.; Tung, E.; Roffler, S.R. Cancer Res., 1992, 52, 4484.
12. Bagshawe, K.D. Drug Dev. Res., 1995, 34, 220.
13. Florent, J.C.; Dong, X,; Gauldel, Gilbert, Mitaku, S.; Claude Monneret, C.; Gesson, J.P.; Jacquesy, J.C.; Mondon, M.; Renoux, B.; Andrianomenjanahary, S.; Michel, S.; Koch, M.; Tillequin, F.; Gerken, M.; Czech, Joerg,; Straub, R.; Bosslet, K. J. Med. Chem., 1998, 41, 3572.
14. Vingerhoeds, M.H.; Haisma, H.J.; Belliot, S.O.; Smit, R.H.P.; Crommelin, D.J.A.; Storn, G. Pharma. Res., 1996, 13, 4, 604.
15. Niculescu-Duvaz, I.; Springer, C.J. Anti-Cancer Drug Des., 1995, 10, 361.
16. Niculescu-Duvaz, I.; Springer, C.J., Adv. Drug Delivery. Res., 1997, 26, 151.
17. Vingerhoeds, M.H.; Haisma, H.J.; van Muijen, M.; van de Rijt, R.B.J.; Crommeline, D.J.A.; Storm, G. Federation of European Biochememical Societies, Letters, 13466, 1993, 336, 3, 485.
18. Blakey, D.C.; Burke, P.J.; Davies, D.H.; Dowell, R.I.; Melton, R.G.; Springer, C.J.; Wright, A.F. Biochem. Soc. Trans., 1995, 23, 1047.
19. Melton, R.G.; Knox, R.J.; Connors, T.A. Drugs Future, 1996, 21, 167.
20. Hay, M.P.; Denny, W.A. Drugs Future, 1996, 21, 917.
21. Melton, R.G.; Sherwood, R.F. J. Natl. Cancer Inst., 1996, 88, 153.
22. Connors, T.A. Biochemie, 1978, 60, 979.
23. Connors, T.A.; Whisson, M.E. Nature (London), 1966, 210, 866.
24. Young, C.W.; Yagoda, A.; Bittar, E.S.; Smith, S.W.; Grabstald, H,; Whitmore, W. Cancer, 1976, 38, 5, 1887.
25. Connors, T.A.; Farmer, P.B.; Foster, A.B.; Gilsenan, A.M.; Jarman, M.; Tisdale, M.J. Biochem. Pharma., 1973, 22, 1971.
26. Babu, S.R.; Wongsurawat, V.S.; Zenser, T.V.; Davis, B.B. Carcinogenesis, 1993, 14, 5, 893.
27. Barua, A.B.; Olson, J.A. J. Lipid. Res., 1985, 26, 10, 1277.
28. Barua, A.B.; Olson, J.A. Biochem. J., 1987, 244, 1, 231.
29. Barua, A.B. Methods Enzynol., 1990, 189, 136.
30. Kyle, R.A.; Costa, G.; Cooper, M.R.; Ogawa, M.; Silver, R.T.; Glidewell, O.; Holland, J.F. Cancer Res., 1973, 33, 956.
31. Monson, T.P.; Henle, K.J.; Nagle, W.A.; Mansouri, A. Int. J. Radiat. Oncl. Biol. Phys., 1991, 20, 6, 1263.
32. Giller, S.A.; Polis, Y.J. British Patent, 1973, 1390479.
33. Guenthner, T.M.; Lair, N.P. Pharmacology, 1988, 37, 341.
34. Mutlib, A.E.; Nelson, W.L. J. Pharmacol. Exp. Ther., 1990, 252, 2, 593.
35. Parker, A.; Fedor, L. J. Med. Chem., 1982, 25, 1505.
36. Hosoda, H.; Yokohama, H.; Nambara, T. Chem. Phar. Bull., 1984, 32, 10, 4023.
37. Whisson, M.E.; Connors, T.A. Nature, 1965, 206, 689.
38. Bicher, U. Nature, 1974, 252, 726.
39. Dalgaard, I. Acta Chemica Scandinavica Series B, 1983, 37, 923.
40. Bukhari, M.A.; Everett, J.L.; Ross, W.C.J. Biochem. Pharmacol., 1972, 21, 963.
41. Roffler, S.R.; Wang, S.M.; Chern, J.W.; Yeh, M.V.; Tung, E. Biochem. Pharmacol., 1991, 42, 10, 2062.
42. Carlson, T.A.; White, R.M. J. Chem. Phys., 1966, 44, 4510.
43. Lederer, M.C.; Shirley, V.S. Table of Isotopes, 7th Ed., J. Wiley and Sons Inc., New York, 1978.
44. Charlton, D.E.; Booz, J. Radiat. Res., 1981, 87, 10.
45. Humm, J.L.; Charlton, D.E. Int. J. Radiat. Oncl. Biol. Phys., 1989, 17, 351.
46. Paretzke, H.G.; Turner, J.E.; Hamm, R.N.; Wright, H.A.; Ritchie, R.H. J. Chem Phys., 1986, 84, 3182.
47. Pomplun, E. Ph.D. Thesis, University of Duseldorf, Germany, 1987.
48. Pomplun, E.; Booz, J.; Dydejzyk, A.; Feinendegen, L.E. Radiat. Environ. Biophys., 1987, 26, 181.
49. Pomplun, E. Int. J. Radiat. Biol., 1991, 59, 3, 625.
50. Sastry, K.S.R.; Rao, R.W.; Mylaravapu, V.B.; Kassis, A.I.; Adelstein, S.J.; Wright, H.A. Dosimetry of Auger emitters : Physical and Phenomenological Approaches in DNA Damage by Auger emitters (K.I. Baverstock, D.E. Charlton, Eds.), Taylor and Francis, New York, 1988.
51. Unak, P.; Unak, T. Inst. Meth. Phys. Res., 1987, A255, 281.
52. Unak, T.; Ongun, B,; Unak, P. Appl. Radiat. Isot., 1995, 6/7, 661.
53. Unak, T. Radiat. Prot. Dos, 1997, 74, 3, 183.
54. Unak, T.; Unak, P. Conference Proceedings Vol. 59, Nuclear Data for Science and Technology (Eds. : G. Reffo, A. Ventura, C Grandi), SIF, Bologna, 1997.
55. Hofer, K.G. 3rd Int. Radiophar. Dos. Symp. HHS Publication FDA, 1981, 8166, 371.
56. Unak, P.; Unak, T. Appl. Radiat, Isot., 1988, 39, 10, 1037.
57. Charlton, D.E.; Humm, J.L. Int. J. Radiat. Biol., 1988, 53, 353.
58. Hofer, K.G.; Harris, C.R.; Smith, J.M. Int. J. Radiat. Biol., 1975, 28, 225.
59. Krisch, R.E.; Sauri, C.D. Int. J. Radiat. Biol., 1975, 27, 553.
60. Barandsen, G.W. Int. J. Radiat. Biol., 1964, 8, 453.
61. Ritter, M.A.; Cleaver, J.W.; Tobias, C.A. Nature, 1977, 266, 653.
62. Fowler, J.F. Int. J. Radiat. Biol., 1985, 47, 115.
63. Brown, I. High linear energy transfer endoradiotherapeutic drugs for malignant disease, MD Thesis, University of Cambridge, 1987.
64. Howell, W.R.; Narra, V.R.; Rao, D.V.; Sastry, S.R. Radiat. Prot. Dos., 1990, 34, 1/4, 325.
65. Friedman, A.M.; Zalutsky, M.R.; Wung, W. Int. J. Med. Biol., 1977, 4, 219.
66. Brown, I. Int. J. Appl. Radiat. Isot., 1982, 33, 75.
67. Brown, I.; Carpenter, R.N.; Mitchell, J.S. Int. J. Appl. Radiat. Isot., 1984, 35, 843.
68. Brown, I.; Carpenter, N. Radiochimica Acta, 1989, 47, 143.
69. Weinreich, R. Molecular radiotherapy with At-211 in Advances in Hadrontherapy, Proc. of Int. Week on Hadrontherapy (Eds. : U. Amaldi, B. Larsson, Y. Lemoigne), 359, Elsevier, 1996.
70. Wunderlich, G.; Franke, W.G.; Doberenz, I.; Fischer. S. AntiCancer Res. 1997, 17, 1809.
71. Stepanek, J.; Larsson, B.; Weinreich, R. Acta Oncologica, 1996, 35, 863.
72. Unak, T. Microdosimetry of astatine-211 and comparison with that of iodine-125 in Proc. of Int. Seminar on Therapeutic Applications of Radiopharmaceuticals (IAEA-SR-209/53), in press.
73. Unak, T.; Unak, P. Appl. Radiat. Isot., 1996, 47, 7, 645.
74. Unak, T.; Unak.; Ongun, B.; Duman, Y. Appl. Radiat. Isot., 1997, 48, 6, 777.
75. Unak, T.; Akgun, Z.; Kalyoncu, S.; Ozkilic, H.; Erenel, G. Anti-Cancer drug potential of radioiodinated glucuronide conjugate of b-naphthol in Proc. of Int. Sym. on Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy (IAEA-SM-355/86), 1998.
76. Akgun, Z. MSc. Thessis, Supervisor: Unak, T. Ege University, Graduate School of Natural and Physical Sciences, Bornova, Izmir, Turkey, March 2000.
77. Ferguson, L.R.; Turner, M.; Pogai, H.; Denny, W. A. Mutation Res., 1992, 265, 181.
78. Gourdie, T.A.; Prakash, A.S.; Wakelin, P.G.; Woodgate, P.D.; Denny, W. A. J. Med. Chem., 1991, 34, 240.
79. Prakas, A.S.; Denny, W.A.; Gourdie, T. A.; Valu, K.K.; Woddgate, P.D.; Wakelin, L.P.G. Biochemistry, 1990, 29, 9799.
80. Gravatt, G.L.; Baguley, B.C.; Wilson, W.R.; Denny, W.A. J. Med. Chem., 1991, 34, 1552.
81. Hofer, K.G. Keough, G, Smith, J.M. Curr. Top. Radiat. Res. 1977, 12, 335.
82. Hamilton, J.G.; Asling, C.W.; Garrison, W.M. Proc. Soc. Exp. Biol. Med., 1950, 73, 51.
83. Warenius, H.M.; Workman, P.; Blechen, N.M. Br. J. Cancer, 1982, 45, 27.
84. Robinson, D.; Smith, J.N.; Williams, R.T. Biochem. J., 1953, 53, 125.
85. Ishidate, M.; Takitani, S.; Kishi, T. Chem. Pharm. Bull. (Tokyo), 1959, 3, 291.
86. Papot, S.; Combaut, D.; Gesson, J.P. Bioorg. Med. Chem. Lett., 1998, 8, 2545.
87. Takitani, T. Chem. Pharm. Bull. (Tokyo), 1959, 7, 845.
88. Bicker, U. Nature, 1972, 252.
89. Tsou, K-C.; Seligman, A.M. J. Am. Chem. Soc., 1953, 75, 1042.
90. Babu, S.R.; Lakshmi, V.M.; Huang, G.P-W.; Zenser, T.V.; Davis, B.B. Biochem. Pharma., 1996, 51, 1679.
91. Robarge, M.J.; Repa, J.J.; Hanson, K.K.; Seth, S.; Clagett-Dame, M.; Abou-Issa, H.; Curley, R.W. Bioorg. Med. Chem. Lett., 1994, 4, 17.
92. Hays, M.T; Hsu, L. Endocrine Res., 1987, 13, 3, 215.
93. Boigegrain, R-A.; Bonfanti, M.; Fanelli, R.; Airoldi, L. J. Chromatography, 1986, 283, 172.
94. Babu, S.R.; Lakshmi, V.M.; Hsu, F.F.; Zenser, T.V.; Davis, B.B. Carcinogenesis, 1992, 13, 7, 1235.
95. Babu, S.R.; Wongsurawat, V.J.; Zenser, T.V.; Davis, B.B. Carcinogenesis, 1993, 14, 5, 893.
96. Babu, S.R.; Lakshmi, V.M.; Owens, I.D.; Zenser, T.V.; Davis, B.B. Carcinogenesis, 1994, 15, 9, 2003.
97. Zenser, T.V.; Lakshmi, V.M.; Babu, S.R.; Hsu, F.F.; Kane, R.E.; Davis, B.B. Polycyclic Aromatic Compounds, 1994, 7, 145.
98. Zenser, T.V.; Lakshmi, V.M.; Rustan, T.D.; Doll, M.A.; Deitz, A.C.; Davis, B.B.; Hein, D.W. Cancer Res., 1996, 56, 3941.
99. Babu, S.R.; Lakshmi, V.M.; Hsu, F.F.; Kane, R.E.; Zenser, T.V.; Davis, B.B. Carcinogenesis, 1993, 14, 12, 2605.
100. Babu, S.R.; Lakshmi, V.M.; Zenser, T.V.; Davis, B.B. Drug Metabolism and Disposition, 1994, 22, 6, 922.
101. Lakshmi, V.M.; Bell, D.A., Watson, Zenser, T.V.; Davis, B.B. Carcinogenesis, 1995, 16, 7, 1565.
102. Babu, S.R.; Lakshmi, V.M.; Hsu, Zenser, T.V.; Davis, B.B. Carcinogenesis, 1995, 16, 12, 3069.
103. Wilhelm, V.; Bailey, L.C.; Shepard T. J. Chromatograpy, 1992, 578, 231.
104. Haisma, H.J.; Boven, E.; van Muijen, M.; de Jong, J.; van der Vijgh, W.J.; Pinedo, H.M. Br. J. Cancer, 1992, 66, 3, 474.